Skip to NavigationSkip to content

News

0
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir for emergency use in a bid...
0
The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was dangerous...
0
The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access to hydroxychloroquine...
0
Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory failure in...

Features

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to...